SCHEMBL6284804

SCHEMBL6284804

COc1cccc2cc(C(=O)O)sc12.Nc1ccccc1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.49
BCL2L1 Q07817 1/20 0.46
CHRNA7 P36544 3/20 0.46
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 2/20 0.44
HPGD P15428 2/20 0.44
HTR3A P46098 1/20 0.44
HSD17B10 Q99714 1/20 0.43
TBXAS1 P24557 1/20 0.43
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42
ADRA2B P18089 1/20 0.42
PTGS1 P23219 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1850788 0.91 CA2 (0.53) CA2BCL2L1CHRNA7ALDH1A1KDM4E
Anthranilamide SCHEMBL6284801 0.90 CA2 (0.43) CA2BCL2L1CHRNA7ALDH1A1KDM4E
SCHEMBL15697569 0.83 BCL2L1 (0.46) CA2BCL2L1CHRNA7ALDH1A1KDM4E
SCHEMBL3252698 0.82 BCL2L1 (0.53) CA2BCL2L1CHRNA7ALDH1A1KDM4E
SCHEMBL2895989 0.81 ALDH1A1 (0.55) CA2CHRNA7ALDH1A1KDM4EHPGD
SCHEMBL6284802 0.81 LMNA (0.51) CA2CHRNA7ALDH1A1KDM4EHPGD
SCHEMBL6288992 0.81 STING1 (0.56) BCL2L1
SCHEMBL15697497 0.78 BCL2L1 (0.46) BCL2L1CHRNA7ALDH1A1KDM4EHPGD
SCHEMBL17842761 0.77 CHRNA7 (0.53) CA2BCL2L1CHRNA7ALDH1A1KDM4E
SCHEMBL2897570 0.77 CHRNA7 (0.53) BCL2L1CHRNA7ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2005508311-A 2005-03-31 JP claimed
EP-1416928-A2 N-MONOACYLATED DERIVATIVES OF O-PHENYLENEDIAMINES, THEIR SIX MEMBERED HETEROCYCLIC ANALOGUES AND THEIR USE AS PHARMACEUTICAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2004-05-12 EP claimed
WO-2003013484-A2 N-MONOACYLATED DERIVATIVES OF O-PHENYLENEDIAMINES, THEIR SIX MEMBERED HETEROCYCLIC ANALOGUES AND THEIR USE AS PHARMACEUTICAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2003-02-20 WO claimed